Form D · Manufacturing
RxFunction, Inc.
Eden Prairie, MN · CIK 0001713884
Offering snapshot reported Oct 14, 2026 · SEC filing
- Reported sold
- $4.01M Offering amount: $4.29M
- Investors reported
- 41 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 27, 2019 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2026 | Amendment | $4,014,614 | $0vs Oct 17, 2025 | 41 | SEC filing |
| Oct 14, 2026 | Amendment | $7,500,007 | $0vs Oct 17, 2025 | 48 | SEC filing |
| Oct 17, 2025 | Amendment | $4,014,614 | $0vs Nov 6, 2024 | 41 | SEC filing |
| Oct 17, 2025 | Amendment | $7,500,007 | $0vs Nov 6, 2024 | 48 | SEC filing |
| Nov 6, 2024 | Amendment | $7,500,007 | $0vs Nov 15, 2023 | 48 | SEC filing |
| Nov 6, 2024 | Amendment | $4,014,614 | $0vs Nov 15, 2023 | 41 | SEC filing |
| Nov 15, 2023 | Amendment | $4,014,614 | $0vs Nov 21, 2022 | 41 | SEC filing |
| Nov 15, 2023 | Amendment | $7,500,007 | $0vs Nov 21, 2022 | 48 | SEC filing |
| Nov 21, 2022 | Amendment | $4,014,614 | $0vs Mar 10, 2022 | 41 | SEC filing |
| Nov 21, 2022 | Amendment | $7,500,007 | $0vs Mar 9, 2022 | 48 | SEC filing |
| Nov 10, 2022 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Mar 10, 2022 | Amendment | $4,014,614 | $0vs Mar 16, 2021 | 41 | SEC filing |
| Mar 9, 2022 | Amendment | $7,500,007 | $0vs Mar 15, 2021 | 48 | SEC filing |
| Mar 4, 2022 | Amendment | $5,875,000 | $1,875,000vs Mar 18, 2021 | 2 | SEC filing |
| Jan 24, 2022 | Amendment | $3,850,530 | $3,558,134vs Jan 29, 2021 | 33 | SEC filing |
| Mar 18, 2021 | Amendment | $4,000,000 | $0vs Dec 9, 2020 | 2 | SEC filing |
| Mar 16, 2021 | Amendment | $4,014,614 | $0vs Sep 28, 2020 | 41 | SEC filing |
| Mar 15, 2021 | Amendment | $7,500,007 | $0vs Jan 28, 2020 | 48 | SEC filing |
| Jan 29, 2021 | Initial | $292,396 | No comparison | 6 | SEC filing |
| Dec 9, 2020 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
| Sep 28, 2020 | Amendment | $4,014,614 | $3,986,614vs Apr 3, 2019 | 41 | SEC filing |
| Jan 28, 2020 | Amendment | $7,500,007 | $0vs Jan 25, 2019 | 48 | SEC filing |
| Apr 3, 2019 | Initial | $28,000 | No comparison | 1 | SEC filing |
| Jan 25, 2019 | Amendment | $7,500,007 | $3,547,351vs Dec 28, 2017 | 48 | SEC filing |
| Mar 29, 2018 | Initial | $2,056,050 | No comparison | 2 | SEC filing |
| Dec 28, 2017 | Initial | $3,952,656 | No comparison | 25 | SEC filing |
| Aug 11, 2017 | Initial | $100,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $359K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-336327
The underlying offering is complete. The Total Remaining to be Sold reflects $275,978 of Common Stock that is issuable upon exercise of outstanding warrants issued in the offering as reported on Form D filed on 4/3/2019.
The underlying offering is complete and this amendment to the original Form D covers only the Common Stock issuable upon exercise of warrants sold in the underlying offerings.
This amount represents the actual amount paid. The underlying offering is complete.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cedar Point Capital, LLC | 145116 | Cedar Point Capital, LLC · CRD 145116 |
Source: Form D, filed Oct 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mary E. Anderson | Director, Executive |
| Joseph Daniel Leach | Executive |
| Thomas E. Morizio | Director, Executive |
| Richard Nigon | Director |
| Lars Oddsson | Director, Executive |
| Richard Offerdahl | Director |
| Robert Rinek | Director |
| Kevin Roche | Director |
| Joseph Schauer | Executive |
Issuer details
Industry: Manufacturing (See others in industry)
Address:Eden Prairie, MN, 55344